Related Experiment Video
Updated: Aug 13, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Astatine-211 based radionuclide therapy: Current clinical trial landscape
Per Albertsson1,2, Tom Bäck3, Karin Bergmark1,2
1Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Abstract:
Astatine-211 (211At) has physical properties that make it one of the top candidates for use as a radiation source for alpha particle-based radionuclide therapy, also referred to as targeted alpha therapy (TAT). Here, we summarize the main results of the completed clinical trials, further describe ongoing trials, and discuss future prospects.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Clinical Trials
There are four phases in a clinical trial. A phase one...

